"Designing Growth Strategies is in our DNA"

U.S. Inflammatory Bowel Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Disease Indication (Ulcerative Colitis and Crohns Disease), By Route of Administration (Oral and Injectables), By Drug Class (IL Inhibitors, TNF Inhibitors, Anti-integrin, JAK Inhibitors, Corticosteroids, ASA Drugs, and Others), By Distribution Channel (Hospital Pharmacy and Retail Pharmacy & Other), and Country Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108774

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Inflammatory Bowel Disease in U.S., 2022
    2. Average Length of Therapy for Inflammatory Bowel Disease
    3. Statistical Overview of Patients Undergoing Different Therapies
    4. New Product Launches, By Key Players
    5. Key Industry Developments – Mergers, Acquisitions, and Partnerships
    6. Pipeline Analysis, By Key Players
    7. Impact of COVID-19 on the Market
  5. U.S. Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2030 
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn's Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Other
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. UCB S.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Bausch Health Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. CELLTRION INC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2030

Table 02: U.S. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2030

Table 03: U.S. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019–2030

Table 04: U.S. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Figure 01: U.S. Inflammatory Bowel Disease Treatment Market Revenue Breakdown (USD billion, %), By Disease Indication, 2022 & 2030

Figure 02: U.S. Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2022 & 2030

Figure 03: U.S. Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2022 & 2030

Figure 04: U.S. Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2022 & 2030

Figure 05: U.S. Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 06: U.S. Inflammatory Bowel Disease Treatment Market Share (%), 2022

U.S. Inflammatory Bowel Disease Treatment Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Consulting Services
    How will you benefit from our consulting services ?